Abstract
The O-allylphenyl (AP) anomeric moiety was investigated as a new leaving group that can be activated for chemical glycosylation under a variety of conditions, through both direct and remote pathways. Differentiation between the two activation pathways was achieved in a mechanistic study. The orthogonal-type activation of the AP moiety along with common thioglycosides allows for the execution of efficient oligosaccharide assembly.
Keywords: carbohydrates, glycosylation, leaving group, oligosaccharides, orthogonal strategy, selective activation
Introduction
Current knowledge about the key roles of carbohydrates is still limited. However, thanks to the explosive growth of the field of glycobiology in recent years, we have already learned that carbohydrates are involved in a broad range of vital biological processes (e.g., fertilization, anti-inflammation, immunoresponse, joint lubrication, antigenic determination) [1]. Carbohydrates are also involved in many harmful processes (e.g., bacterial and viral infections, development of tumors, metastasis, tissue rejection, congenital disorders). The fact that many of these processes are directly associated with the pathogenesis of deadly diseases, including AIDS, cancer, pneumonia, septicemia, hepatitis and malaria [2–4], has been particularly stimulating for major scientific efforts in the field of modern glycosciences. The traditional chemical synthesis of oligosaccharides is lengthy because it involves multiple manipulations of protecting and/or leaving groups between glycosylation steps [5]. Many advanced strategies that shorten the oligosaccharide assembly by minimizing or even eliminating additional manipulations between coupling steps, are based either on chemoselective or on selective activation of leaving groups [6]. The use of selective activation [7] offers more flexibility than that of the chemoselective activation which relies on the nature of the protecting groups [8], and Ogawa’s orthogonal strategy is conceptually the most attractive approach that has been developed to date [9–12]. This technique implies the use of two orthogonal leaving groups, LGa and LGb, the selective activation of which can be reiterated to give streamlined access to oligosaccharides (Scheme 1).
Scheme 1.
Orthogonal strategy introduced by Ogawa et al.
Yet, the orthogonal strategy remains underdeveloped, with too few examples to become universally applicable. Only Ogawa’s S-phenyl (SPh) versus fluoride [9–10,13] and our thioimidate-based approaches [14–16] are known. A very promising orthogonality was shown for O-pentenyl versus O-propargyl glycosides by Hotha et al. [17] and for S-glycosyl O-methyl phenylcarbamothioate (SNea) versus thioglycosides/thioimidates by us [18], but still their applicability to multistep synthesis remains to be proven. Working to expand this concept, our group reported a related, albeit less flexible, semiorthogonal approach with the use of S-ethyl and O-pentenyl leaving groups [19], which was later extended to fluoride/O-pentenyl combination by Fraser-Reid and Lopez [20]. Oxygen- [21] and sulfur-based [22] leaving groups fit into many expeditious strategies for oligosaccharide synthesis [6]. However, suitable reaction conditions for the orthogonal activation of these two classes of leaving groups are yet to be found. Commonly, O-glycosides are too stable to be used as effective glycosyl donors [21]. Pent-4-enyl O-glycosides introduced by Fraser-Reid are unique in this category of leaving groups, because they can be glycosidated under mild conditions by using I+ generated in situ. Also this method has its limitations since I+ can also activate thioglycosides. Indeed, only the semiorthogonality of the O-pentenyl and SEt leaving groups could be established [19]. Additionally, 4-pentenol is rather expensive ($ 323/50 g, Aldrich), and although O-pentenyl can be introduced from the anomeric acetate directly, the most economical synthesis includes a three-step protocol, with halide, orthoester, and the rearrangement of the latter to glycoside.
Results and Discussion
As a part of the ongoing research effort to develop versatile building blocks, we present herein the development of a new ortho-allylphenyl (AP) leaving group. In line with other efforts [23–26], the AP group was specifically designed to address the drawbacks of O-pentenyl glycosides and to create a more flexible approach for oligosaccharide synthesis. Concomitantly with our studies, Hung et al. came up with essentially the same idea and reported the synthesis of AP mannosides and their activation for O-mannosylation in the presence of ICl/AgOTf [27].
The following considerations driving our efforts were of particular relevance. First, chemists have been making aryl glycosides for some 130 years [28], and many excellent protocols for their synthesis are available [29]. We determined that AP glycosides can be readily obtained from the corresponding peracetate by using inexpensive 2-allylphenol ($ 35/100 g, Aldrich) in the presence of BF3·Et2O. For instance, acetylated AP β-D-glucopyranoside was obtained in 92% yield. Second, we anticipated that the same promoters used for O-pentenyl activation [30] can also activate the AP leaving group. However, since AP glycosides bear structural features of both aryl and pentenyl glycosides, they should offer a more versatile activation profile than either class of the leaving group. Our working hypothesis is that activation of the AP leaving group with I+ takes place by the formation of an epi-iodonium ion, which is then opened with the anomeric oxygen, similarly to that known for O-pentenyl glycosides [30]. It is possible that the activation of the AP leaving group can also be achieved with TMSOTf or BF3·Et2O via the direct anomeric activation pathway, which was expected to become the key feature of the AP-mediated glycosylation approach in comparison to that of both O-pentenyl or thioglycosides. As a result, this pathway may offer a suitable platform for developing a fully orthogonal approach in combination with thioglycosides.
To pursue this methodology we obtained a range of differently protected AP glucosides, including perbenzylated 1a, perbenzoylated 1b, and derivative 1c equipped with the superarming protecting-group pattern (2-O-benzoyl-3,4,6-tri-O-benzyl) [31]. For comparison, we also obtained the AP donor 1d of the D-galacto series. With glycosyl donors 1a–d in hand, we began evaluating their applicability to chemical glycosylation using a range of standard glycosyl acceptors 2–5 [18]. Encouragingly, the reaction of glycosyl donor 1a with the primary glycosyl acceptor 2 in the presence of TMSOTf was completed within 15 min and provided the corresponding disaccharide 6a in 82% yield (Table 1, entry 1). As expected, when a control experiment was set up with MeOTf, no glycosylation of 2 took place (Table 1, entry 2). The fact that the AP group in 1a can be activated with TMSOTf, but not with MeOTf, offers a basis for exploring its orthogonality to thioglycosides. This is because thioglycosides show a completely opposite reactivity trend, namely no reaction with TMSOTf and smooth glycosylation with MeOTf [32].
Table 1.
Glycosylation of AP glycosyl donors 1a–d.
![]() | ||||
| entry | donor + acceptor | conditionsa | time | product (yield, α/β ratio) |
| 1 | 1a + 2 | TMSOTf, rt | 15 min | 6a (82%, 2.7/1) |
| 2 | 1a + 2 | MeOTf, rt | 24 h | no reaction |
| 3 | 1a + 2 | NIS/TMSOTf, 0 °C | 40 min | 6a (80%, 1.4/1) |
| 4 | 1a + 2 | NIS/TfOH, 0 °C | 15 min | 6a (90%, 1/1.5) |
| 5 | 1a + 3 | NIS/TfOH, 0 °C | 4 h | 7a (73%, 1.2/1) |
| 6 | 1a + 4 | NIS/TfOH, 0 °C | 30 min | 8a (82%, 1.0/1) |
| 7 | 1a + 5 | NIS/TfOH, 0 °C | 3 h | 9a (72%, 1/1.3) |
| 8 | 1b + 2 | MeOTf, rt | 24 h | no reaction |
| 9 | 1b + 2 | TMSOTf, rt | 24 h | no reaction |
| 10 | 1b + 2 | NIS/TMSOTf, 0 °C | 6 h | 6b (77%, β only) |
| 11 | 1b + 2 | NIS/TfOH, 0 °C | 2 h | 6b (71%, β only) |
| 12 | 1b + 5 | NIS/TfOH, 0 °C | 3 h | 9b (78%, β only) |
| 13 | 1c + 2 | MeOTf, rt | 24 h | no reaction |
| 14 | 1c + 2 | TMSOTf, −20 °C | 2.5 h | 6c (73%, β only) |
| 15 | 1c + 2 | NIS/TMSOTf, 0 °C | 10 min | 6c (84%, β only) |
| 16 | 1c + 2 | NIS/TfOH, −20 °C | 15 min | 6c (93%, β only) |
| 17 | 1d + 2 | NIS/TfOH, 0 °C | 15 min | 6d (85%, 1.5/1) |
| 18 | 1d + 3 | NIS/TfOH, 0 °C | 4 h | 7d (81%, 1.2/1) |
| 19 | 1d + 4 | NIS/TfOH, 0 °C | 30 min | 8d (82%, 1.0/1) |
| 20 | 1d + 5 | NIS/TfOH, 0 °C | 2 h | 9d (80%, 3.0/1) |
aperformed in the presence of molecular sieves 4 Å (or 3 Å in MeOTf-promoted reactions, entries 2, 8, and 13).
NIS/TMSOTf is a powerful promoter for the activation of both O-pentenyl and thioglycosides. It was also found to be effective for the activation of AP glycosyl donor 1a, upon which disaccharide 6a was obtained in 80% yield. Even faster reaction and higher yield was obtained by using the NIS/TfOH promoter system, wherein the resulting disaccharide 6a was obtained in 90% yield (Table 1, entry 4). The latter reaction conditions were chosen for use in the investigation of the glycosylation of the secondary glycosyl acceptors 3–5.
These couplings were also proven to be feasible, and the corresponding disaccharides 7a–9a were obtained in 72–82% yield (Table 1, entries 5–7). As anticipated, the reactivity of the perbenzoylated (disarmed) counterpart 1b was significantly lower than that of 1a, and TMSOTf-promoted glycosylation of 1b was practically ineffective (Table 1, entry 9). This observation along with the fact that the armed AP leaving group in 1a can be readily activated with TMSOTf (Table 1, entry 1) suggests that AP glycosides can be applied in accordance with the classic armed–disarmed strategy [33]. NIS-promoted glycosylations of 1b have proven to be of preparative value and the desired disaccharides 6b and 9b were isolated in 71–78% yield (Table 1, entries 10–12). In order to gain a more flexible activation profile for the synthesis of 1,2-trans glycosides, we also investigated AP glycosyl donor 1c, bearing a superarming protecting-group pattern [31]. As expected, all of the previously established activation conditions were very effective, and glycosylation of 1c with acceptor 2 readily produced disaccharide 6c (Table 1, entries 14–16). Again, particularly efficient was the NIS/TfOH-promoted reaction wherein disaccharide 6c was isolated in 93% yield (Table 1, entry 16). To broaden the scope of the AP approach, we tested its applicability to the synthesis of D-galactosides, which are a highly important and abundant sugar series. All glycosylations of AP donor 1d proceeded smoothly in the presence of NIS/TfOH and the corresponding disaccharides 6d–9d were obtained in 80–85% yield (Table 1, entries 17–20). To verify the two anticipated activation pathways by which the AP group may depart, all components of the key experiments (Table 1, entries 1 and 3) wherein glycosyl donor 1a reacted with glycosyl acceptor 2 in the presence of TMSOTf and NIS/TMSOTf, respectively, were separated and analyzed. In the TMSOTf-promoted reaction, (o-allylphenoxy)trimethylsilane (10) was isolated and identified by comparison with analytical data obtained from a commercial sample. This result suggests that the activation of the AP moiety with TMSOTf takes place through the anomeric oxygen atom (A, Pathway A, Scheme 2). In the NIS/TMSOTf-promoted reaction, 2-iodomethyl-2,3-dihydrobenzofuran (11) [34] was isolated and its identity was proven by spectral methods indicating that activation with I+ takes place through the remote allyl moiety (B, Pathway B). In addition, in the latter experiment we detected the presence of adduct 12, which was formed as the result of a competing attack of the glycosyl acceptor oxygen, as opposed to endocyclization of B through the anomeric oxygen leading to oxacarbenium intermediate C.
Scheme 2.
Determination of the AP activation pathways.
In accordance with Fraser-Reid’s armed–disarmed approach, electronically activated (armed) glycosyl donors are chemoselectively activated over deactivated (disarmed) glycosyl acceptors bearing the same type of leaving group [30,35]. To explore this avenue, we obtained a disarmed (benzoylated) 6-OH AP glycosyl acceptor 13 (Supporting Information File 1), which was coupled with the armed AP glycosyl donor 1a in the presence of TMSOTf. As anticipated, this reaction was feasible and the expected disaccharide 14 was obtained in 78% yield (Table 2, entry 1). With the ultimate goal of developing distinct orthogonal differentiation of AP and thioglycosides, we next obtained glycosyl acceptor 15 [36] equipped with an ethylthio leaving group. TMSOTf-promoted chemoselective glycosylation between building blocks 1a and 15 produced the expected disaccharide 16 in 71% yield (Table 2, entry 2).
Table 2.
AP glycosides as glycosyl donors and acceptors in chemoselective and selective activations.
![]() | ||||
| entry | donor; acceptor |
promotera | time | product (yield, α/β ratio) |
| 1 |
1a (LG1 = OAP, R1 = R2 = Bn); 13 (LG2 = OAP, R3 = Bz) |
A | 10 min | 14 (78%, 1.0/1) |
| 2 |
1a; 15 (LG2 = SEt, R3 = Bn) |
A | 15 min | 16 (71%, 1.0/1) |
| 3 |
1a; 17(LG2 = STol, R3 = Bz) |
A | 1 h | 18 (75%, 2.4/1) |
| 4 |
1a; 19 (LG2 = SPh, R3 = Bn) |
A | 1 h | 20 (90%, 1.0/1) |
| 5 |
1a; 21 (LG2 = SPh, R3 = Bz) |
A | 2 h | 22 (98%, 1.8/1) |
| 6 |
1c (LG1 = OAP, R1 = Bz, R2 = Bn); 21 |
A | 30 min | 23 (75%, β only) |
| 7 |
24 (LG1 = SEt, R1 = R2 = Bn); 25 (LG2 = OAP, R3 = Bn) |
B | 2 h | 26 (82%, 1.8/1) |
| 8 |
27 (LG1 = STaz, R1 = R2 = Bn); 25 |
B | 1 h | 26 (78%, 1.0/1) |
| 9 |
28 (LG1 = STol, R1 = R2 = Bn); 25 |
B | 4 h | 26 (97%, 1.2/1) |
| 10 |
29 (LG1 = SPh, R1 = R2 = Bn); 25 |
B | 6 h | 26 (90%, 1.0/1) |
aperformed in the presence of molecular sieves 4 Å (A: TMSOTf) or 3 Å (B: MeOTf) at rt or 0 °C (entry 6).
In a selective activation fashion, glycosyl acceptors 17 [37] and 19 [38], equipped with S-tolyl (STol) and S-phenyl leaving groups, respectively, were glycosylated with AP glycosyl donor 1a to afford disaccharides 18 and 20 in 75 and 90% yield, respectively (Table 2, entries 3 and 4). Also the disarmed SPh acceptor 21 [39] led to disaccharide 22 in 98% yield. The synthesis of a 1,2-trans-linked disaccharide was also possible with glycosyl donor 1c leading to the corresponding β-linked disaccharide 23 in 75% yield (Table 2, entry 6). This series of experiments clearly demonstrates that the AP leaving group can be reliably activated with TMSOTf in the presence of S-alkyl/aryl leaving groups. We next investigated glycosyl acceptor 25 equipped with the AP leaving group. MeOTf-promoted glycosylation of SEt, STaz, STol, and SPh glycosyl donors 24 [40], 27 [14], 28 [41], and 29 [42], respectively, with acceptor 25 afforded the respective disaccharide 26 in 78–97% yield (Table 2, entries 7–10). These series of results indicates a completely orthogonal character of AP and the thioglycosides. To expand this observation, disaccharide 26 was coupled with thioglycoside acceptor 21 in the presence of TMSOTf leading to trisaccharide 30 in 90% (Scheme 3). Since 30 is equipped with the SPh anomeric leaving group, it is available for further chain elongation directly. In a similar fashion, thioglycoside disaccharide 16 was coupled with AP acceptors 25 and 13 in the presence of MeOTf to afford trisaccharides 31 and 32 in 50 and 80% yield, respectively. Since these trisaccharides are equipped with the AP leaving group, their direct application to further chain elongation can be envisaged.
Scheme 3.
AP building blocks in oligosaccharide synthesis.
Conclusion
In conclusion, we investigated the O-allylphenyl (AP) anomeric moiety as a new leaving group that can be activated for chemical glycosylation under a variety of conditions including Lewis acid and iodonium ion mediated pathways. The two activation pathways were confirmed by a mechanistic study. We also demonstrated that the application of the AP moiety allows executing oligosaccharide assembly by an orthogonal concept. The application of the AP glycosides may stretch well beyond their initial intended purpose because the alkene moiety can be utilized in a variety of other modes. Similar to that of O-pentenyl [30], it can be temporarily deactivated toward the I+ activation pathway by the addition of Br2, which can be reverted as needed (active–latent strategy). Direct conjugation of the AP moiety to biomolecules, monolayers, arrays, etc., should be possible by executing thiol–ene chemistry [43], ozonolysis/reductive amination [44–46], or other ligation protocols [47–48].
Experimental
General remarks
Column chromatography was performed on silica gel 60 (EM Science, 70–230 mesh), reactions were monitored by TLC on Kieselgel 60 F254 (EM Science). The compounds were detected by examination under UV light and by charring with 10% sulfuric acid in methanol. Solvents were removed under reduced pressure at <40 °C. CH2Cl2 and ClCH2CH2Cl were distilled from CaH2, directly prior to application. Anhydrous DMF (EM Science) was used as received. Methanol was dried by heating under reflux with magnesium methoxide, distilled and stored under argon. Pyridine and acetonitrile were dried by heating under reflux with CaH2 and then distilled and stored over molecular sieves (3 Å). Molecular sieves (3 Å or 4 Å), used for reactions, were crushed and activated in vacuo at 390 °C during 8 h in the first instance and then for 2–3 h at 390 °C directly prior to application. DOWEX MONOSPHERE 650C (H) was washed three times with MeOH and stored under MeOH. Optical rotations were measured with a Jasco P-1020 polarimeter. 1H NMR spectra were recorded in CDCl3 at 300 MHz; 13C NMR spectra were recorded in CDCl3 at 75 MHz (Bruker Avance) or 125 MHz (Varian). Anomeric ratios were determined by comparison of the integral intensities of the respective groups of signals in the 1H NMR spectra. HRMS determinations were made with the use of a JEOL MStation (JMS-700) mass spectrometer.
Synthesis of glycosides
Typical MeOTf-promoted glycosylation procedure (Method A). A mixture of glycosyl donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular sieves (3 Å, 300 mg) in 1,2-dichloroethane (1.4 mL) was stirred under argon for 1 h. MeOTf (0.33 mmol) was added and the reaction mixture was monitored by TLC. Upon completion (Table 1, Table 2), the solid was filtered off and the residue was rinsed with CH2Cl2. The combined filtrate (30 mL) was washed with 20% aq NaHCO3 (10 mL) and water (3 × 10 mL). The organic layer was separated, dried with MgSO4 and concentrated in vacuo. The residue was purified by silica gel column chromatography (ethyl acetate/hexanes gradient elution) to afford the corresponding oligosaccharide.
Typical TMSOTf-promoted glycosylation procedure (Method B). A mixture of glycosyl donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular sieves (4 Å, 150 mg) in 1,2-dichloroethane (1.6 mL) was stirred under argon for 1 h. TMSOTf (0.22 mmol) was added and the reaction mixture was monitored by TLC. Upon completion (Table 1, Table 2), the solid was filtered off and the residue was rinsed with CH2Cl2. The combined filtrate (30 mL) was washed with 20% aq NaHCO3 (10 mL) and water (3 × 10 mL). The organic layer was separated, dried with MgSO4 and concentrated in vacuo. The residue was purified by silica gel column chromatography (ethyl acetate/hexanes gradient elution) to afford the corresponding oligosaccharide.
Typical NIS/TfOH-promoted glycosylation procedure (Method C). A mixture of glycosyl donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular sieves (4 Å, 150 mg) in 1,2-dichloroethane (1.6 mL) was stirred under argon for 1 h. NIS (0.22 mmol) and TfOH (0.022 mmol) were added and the reaction mixture was monitored by TLC. Upon completion, the mixture was diluted with CH2Cl2, the solid was filtered off, and the residue was rinsed with CH2Cl2. The combined filtrate (30 mL) was washed with 10% aq Na2S2O3 (10 mL) and water (3 × 10 mL). The organic layer was separated, dried with MgSO4 and concentrated in vacuo. The residue was purified by silica gel column chromatography (ethyl acetate/hexanes gradient elution) to afford the corresponding oligosaccharide.
Typical NIS/TMSOTf-promoted glycosylation procedure (Method D). A mixture of glycosyl donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular sieves (4 Å, 150 mg) in 1,2-dichloroethane (1.6 mL) was stirred under argon for 1 h. NIS (0.22 mmol) and TMSOTf (0.022 mmol) were added and the reaction mixture was monitored by TLC. Upon completion, the mixture was diluted with CH2Cl2, the solid was filtered off, and the residue was rinsed with CH2Cl2. The combined filtrate (30 mL) was washed with 10% aq Na2S2O3 (10 mL) and water (3 × 10 mL). The organic layer was separated, dried with MgSO4 and concentrated in vacuo. The residue was purified by silica gel column chromatography (ethyl acetate/hexanes gradient elution) to afford the corresponding oligosaccharide.
Supporting Information
Experimental procedures, extended experimental data, 1H and 13C NMR spectra for all new compounds.
Acknowledgments
This work was supported by an award from the NIGMS (GM077170). H. D. P. is grateful to UMSL Graduate School for proving her with the Dissertation Fellowship. Dr. Winter and Mr. Kramer (UM – St. Louis) are thanked for HRMS determinations.
This article is part of the Thematic Series "Synthesis in the glycosciences II".
References
- 1.Varki A, Cummings R D, Esko J D, et al. Essentials of Glycobiology. New York: CSH Press; 2009. [PubMed] [Google Scholar]
- 2.Witczak Z J. Carbohydrates as new and old targets for future drug design. In: Witczak Z J, Nieforth K A, editors. Carbohydrates in Drug Design. New York: Marcel Dekker Inc.; 1997. pp. 1–37. [Google Scholar]
- 3.Wong C-H, editor. Carbohydrate-Based Drug Discovery. Weinheim: Wiley-VCH; 2003. [DOI] [Google Scholar]
- 4.Klyosov A A, Witczak Z J, Platt D, editors. Carbohydrate Drug Design. Vol. 932. Washington: ACS; 2006. ((ACS Symposium Series)). [DOI] [Google Scholar]
- 5.Zhu X, Schmidt R R. Angew Chem, Int Ed. 2009;48:1900–1934. doi: 10.1002/anie.200802036. [DOI] [PubMed] [Google Scholar]
- 6.Smoot J T, Demchenko A V. Adv Carbohydr Chem Biochem. 2009;62:161–250. doi: 10.1016/S0065-2318(09)00005-5. [DOI] [PubMed] [Google Scholar]
- 7.Kaeothip S, Demchenko A V. Carbohydr Res. 2011;346:1371–1388. doi: 10.1016/j.carres.2011.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Premathilake H D, Demchenko A V. Top Curr Chem. 2011;301:189–221. doi: 10.1007/128_2010_106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kanie O, Ito Y, Ogawa T. J Am Chem Soc. 1994;116:12073–12074. doi: 10.1021/ja00105a066. [DOI] [Google Scholar]
- 10.Ito Y, Kanie O, Ogawa T. Angew Chem, Int Ed Engl. 1996;35:2510–2512. doi: 10.1002/anie.199625101. [DOI] [Google Scholar]
- 11.Paulsen H. Angew Chem, Int Ed Engl. 1995;34:1432–1434. doi: 10.1002/anie.199514321. [DOI] [Google Scholar]
- 12.Kanie O. Orthogonal Strategy in Oligosaccharide Synthesis. In: Ernst B, Hart G W, Sinaý P, editors. Carbohydrates in Chemistry and Biology. Weinheim, New York: Wiley-VCH; 2000. pp. 407–426. [DOI] [Google Scholar]
- 13.Kanie O, Ohtsuka I, Ako T, Daikoku S, Kanie Y, Kato R. Angew Chem, Int Ed. 2006;45:3851–3854. doi: 10.1002/anie.200600433. [DOI] [PubMed] [Google Scholar]
- 14.Demchenko A V, Pornsuriyasak P, De Meo C, Malysheva N N. Angew Chem, Int Ed. 2004;43:3069–3072. doi: 10.1002/anie.200454047. [DOI] [PubMed] [Google Scholar]
- 15.Pornsuriyasak P, Demchenko A V. Chem–Eur J. 2006;12:6630–6646. doi: 10.1002/chem.200600262. [DOI] [PubMed] [Google Scholar]
- 16.Kaeothip S, Pornsuriyasak P, Rath N P, Demchenko A V. Org Lett. 2009;11:799–802. doi: 10.1021/ol802740b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Vidadala S R, Thadke S A, Hotha S. J Org Chem. 2009;74:9233–9236. doi: 10.1021/jo901837z. [DOI] [PubMed] [Google Scholar]
- 18.Ranade S C, Kaeothip S, Demchenko A V. Org Lett. 2010;12:5628–5631. doi: 10.1021/ol1023079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Demchenko A V, De Meo C. Tetrahedron Lett. 2002;43:8819–8822. doi: 10.1016/S0040-4039(02)02235-9. [DOI] [Google Scholar]
- 20.López J C, Uriel C, Guillamón-Martín A, Valverde S, Gómez A M. Org Lett. 2007;9:2759–2762. doi: 10.1021/ol070753r. [DOI] [PubMed] [Google Scholar]
- 21.Kim K-S, Jeon H-B. Anomeric transglycosylation. In: Demchenko A V, editor. Handbook of Chemical Glycosylation: Advances in Stereoselectivity and Therapeutic Relevance. Weinheim, Germany: Wiley-VCH; 2008. pp. 185–223. [Google Scholar]
- 22.Zhong W, Boons G-J. Glycoside synthesis from 1-Sulfur/Selenium-Substituted Derivatives: Thioglycosides in Oligosaccharide Synthesis. In: Demchenko A V, editor. Handbook of Chemical Glycosylation: Advances in Stereoselectivity and Therapeutic Relevance. Weinheim, Germany: Wiley-VCH; 2008. pp. 261–303. [Google Scholar]
- 23.Rodebaugh R, Fraser-Reid B. Tetrahedron. 1996;52:7663–7678. doi: 10.1016/S0040-4020(96)00349-3. [DOI] [Google Scholar]
- 24.Rodebaugh R, Fraser-Reid B. J Am Chem Soc. 1994;116:3155–3156. doi: 10.1021/ja00086a068. [DOI] [Google Scholar]
- 25.Lee J-C, Pan G-R, Kulkarni S S, Luo S-Y, Liao C-C, Hung S-C. Tetrahedron Lett. 2006;47:1621–1624. doi: 10.1016/j.tetlet.2005.12.127. [DOI] [Google Scholar]
- 26.Fortin M, Kaplan J, Pham K, Kirk S, Andrade R B. Org Lett. 2009;11:3594–3597. doi: 10.1021/ol901313z. [DOI] [PubMed] [Google Scholar]
- 27.Luo S-Y, Tripathi A, Zulueta M M L, Hung S-C. Carbohydr Res. 2012 doi: 10.1016/j.carres.2012.01.022. [DOI] [PubMed] [Google Scholar]
- 28.Michael A. Am Chem J. 1879;1:305–312. [Google Scholar]
- 29.Jacobsson M, Malmberg J, Ellervik U. Carbohydr Res. 2006;341:1266–1281. doi: 10.1016/j.carres.2006.04.004. [DOI] [PubMed] [Google Scholar]
- 30.Fraser-Reid B, Udodong U E, Wu Z, Ottosson H, Merritt J R, Rao C S, Roberts C, Madsen R. Synlett. 1992:927–942. doi: 10.1055/s-1992-21543. and references therein. [DOI] [Google Scholar]
- 31.Mydock L K, Demchenko A V. Org Lett. 2008;10:2103–2106. doi: 10.1021/ol800345j. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Lönn H. J Carbohydr Chem. 1987;6:301–306. doi: 10.1080/07328308708058879. [DOI] [Google Scholar]
- 33.Fraser-Reid B, Wu Z, Udodong U E, Ottosson H. J Org Chem. 1990;55:6068–6070. doi: 10.1021/jo00312a004. [DOI] [Google Scholar]
- 34.Sheng S, Hu M, Wu D, Cai M, Huang X. Lett Org Chem. 2009;6:345–348. [Google Scholar]
- 35.Mootoo D R, Konradsson P, Udodong U E, Fraser-Reid B. J Am Chem Soc. 1988;110:5583–5584. doi: 10.1021/ja00224a060. [DOI] [Google Scholar]
- 36.Fei C, Chan T H. Acta Chim Sin (Engl Ed) 1989:258–264. [Google Scholar]
- 37.Huang X, Huang L, Wang H, Ye X-S. Angew Chem, Int Ed. 2004;43:5221–5224. doi: 10.1002/anie.200460176. [DOI] [PubMed] [Google Scholar]
- 38.Pfäffli P J, Hixson S H, Anderson L. Carbohydr Res. 1972;23:195–206. doi: 10.1016/S0008-6215(00)88025-8. [DOI] [Google Scholar]
- 39.Sliedregt L A J M, van der Marel G A, van Boom J H. Tetrahedron Lett. 1994;35:4015–4018. doi: 10.1016/S0040-4039(00)76728-1. [DOI] [Google Scholar]
- 40.Kaeothip S, Pornsuriyasak P, Demchenko A V. Tetrahedron Lett. 2008;49:1542–1545. doi: 10.1016/j.tetlet.2007.12.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.France R R, Compton R G, Davis B G, Fairbanks A J, Rees N V, Wadhawan J D. Org Biomol Chem. 2004;2:2195–2202. doi: 10.1039/b316728c. [DOI] [PubMed] [Google Scholar]
- 42.Dinkelaar J, de Jong A R, van Meer R, Somers M, Lodder G, Overkleeft H S, Codée J D C, van der Marel G A. J Org Chem. 2009;74:4982–4991. doi: 10.1021/jo900662v. [DOI] [PubMed] [Google Scholar]
- 43.Hoyle C E, Bowman C N. Angew Chem, Int Ed. 2010;49:1540–1573. doi: 10.1002/anie.200903924. [DOI] [PubMed] [Google Scholar]
- 44.Rele S M, Iyer S S, Baskaran S, Chaikof E L. J Org Chem. 2004;69:9159–9170. doi: 10.1021/jo049092r. [DOI] [PubMed] [Google Scholar]
- 45.Noti C, de Paz J L, Polito L, Seeberger P H. Chem–Eur J. 2006;12:8664–8686. doi: 10.1002/chem.200601103. [DOI] [PubMed] [Google Scholar]
- 46.Jeon I, Iyer K, Danishefsky S J. J Org Chem. 2009;74:8452–8455. doi: 10.1021/jo901682p. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Pozsgay V, Kubler-Kielb J. Conjugation Methods toward Synthetic Vaccines. In: Roy R, editor. Carbohydrate-Based Vaccines. Vol. 989. 2008. pp. 36–70. ((ACS Symposium Series)). [DOI] [Google Scholar]
- 48.Payne R J, Wong C-H. Chem Commun. 2010;46:21–43. doi: 10.1039/b913845e. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Experimental procedures, extended experimental data, 1H and 13C NMR spectra for all new compounds.





